Código QR (código de barras bidimensional)

Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature

Background: Ovarian cancer (OC) is a significant cause of cancer-related mortality in women globally, with a five-year survival rate of approximately 49%. Standard therapy involves cytoreductive surgery followed by chemotherapy. Its poor prognosis has driven interest in alternative therapies such as...

ver descrição completa

Na minha lista:
Principais autores: Daniela Luvero, Roberto Angioli, Federica Celoro, Francesco Plotti, Corrado Terranova, Federica Guzzo, Gianna Barbara Cundari, Federico Liparulo, Camilla Verdone, Roberto Montera
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2024-06-01
coleção:Pharmaceuticals
Assuntos:
ovarian cancer
PARP inhibitors
maintenance therapy
bevacizumab
Acesso em linha:https://www.mdpi.com/1424-8247/17/6/778
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados